Mid Yorkshire Hospitals Trust backs new cancer blood test

The test is being evaluated by NHS England to explore how PinPoint could benefit patients with suspected cancer in the future.

As part of the trust’s commitment to the assessment, it has appointed two new dedicated nurses to support PinPoint at its breast clinic, with further avenues to be established in the near future.

The trust now joins GPs across the region in working closely with members of the public to recommend the PinPoint test to patients with suspected cancer.

PinPoint Nurses, Mary Counihan and Debbie Shackelton.

As support grows, posters and flyers for the PinPoint Test can be seen in lounges in Wakefield, Leeds, Kirklees and beyond.

Mid Yorkshire Hospitals NHS Trust Executive Vice President Trudie Davies said: “The PinPoint test looks for signs of cancer in the blood and generates a single, highly accurate result – a patient’s chance of having cancer.

“If successful, the test promises to offer shorter waiting times, reduce patient anxiety and improve early cancer detection.

“We hope that, in the future, the PinPoint test will ensure that high-risk patients are prioritized for earlier hospital visits and faster diagnoses, while those at very low risk may not need to go to the hospital.

Pinderfields Hospital, Wakefield.

“Test results within 48 hours will mean hundreds of thousands of patients each year could be saved from sleepless nights worrying if their symptoms could be cancer.

“If you’ve just been referred for a quick appointment at Pinderfields Hospital Breast Clinic for suspected cancer symptoms – as thousands are each year – keep an eye out for a PinPoint Nurse who can help you apply to support the PinPoint evaluation while you’re there.

“At this stage, patients do not receive their test results, but each blood sample collected brings us closer to a better and safer service for friends and loved ones in the future.”

Last year, 2.8 million patients in England were referred by their GPs for urgent cancer investigations after complaining of worrying symptoms.

These tests may include invasive biopsies, colonoscopies, or CT and MRI scans, but despite the increasing number of referrals each year, only seven percent of people are actually diagnosed with cancer.

This means that more than nine out of ten patients are discharged.

The PinPoint system is designed to help patients in two ways. By accurately identifying patients at high risk of cancer, the PinPoint Test will be used to expedite their referrals for investigation.

Faster action means earlier detection and saved lives.

Furthermore, research shows that the PinPoint test is potentially capable of safely ruling out cancer in up to 20% of patients.

That means over 500,000 people each year who could avoid unnecessary testing and get clearance before they get anywhere near a hospital.

The evaluation of the NHS PinPoint test is being carried out across the region by the West Yorkshire and Harrogate Cancer Alliance and if successful, patients in this region will be the first to have access to this new test.

Mid Yorkshire Hospitals Trust backs new cancer blood test

Leave a Reply

Your email address will not be published.

Scroll to top